Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
Rohrbach J, Robinson N, Harcourt G, Hammond E, Gaudieri S, Gorgievski M, Telenti A, Keiser O, Günthard HF, Hirschel B, Hoffmann M, Bernasconi E, Battegay M, Furrer H, Klenerman P, Rauch A; Swiss HIV Cohort Study. Rohrbach J, et al. Among authors: telenti a. Gut. 2010 Sep;59(9):1252-8. doi: 10.1136/gut.2009.205971. Epub 2010 Jul 26. Gut. 2010. PMID: 20660698 Free article. Clinical Trial.
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.
Greub G, Cozzi-Lepri A, Ledergerber B, Staszewski S, Perrin L, Miller V, Francioli P, Furrer H, Battegay M, Vernazza P, Bernasconi E, Günthard HF, Hirschel B, Phillips AN, Telenti A; Frankfurt HIV Clinic Cohort and the Swiss HIV Cohort Study. Greub G, et al. Among authors: telenti a. AIDS. 2002 Sep 27;16(14):1967-9. doi: 10.1097/00002030-200209270-00017. AIDS. 2002. PMID: 12351960 No abstract available.
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M; Swiss HIV Cohort Study Group. Kaufmann GR, et al. Among authors: telenti a. Arch Intern Med. 2003 Oct 13;163(18):2187-95. doi: 10.1001/archinte.163.18.2187. Arch Intern Med. 2003. PMID: 14557216
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Rotger M, Bayard C, Taffé P, Martinez R, Cavassini M, Bernasconi E, Battegay M, Hirschel B, Furrer H, Witteck A, Weber R, Ledergerber B, Telenti A, Tarr PE; Swiss HIV Cohort Study. Rotger M, et al. Among authors: telenti a. Circ Cardiovasc Genet. 2009 Dec;2(6):621-8. doi: 10.1161/CIRCGENETICS.109.874412. Epub 2009 Sep 18. Circ Cardiovasc Genet. 2009. PMID: 20031643
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.
Rotger M, Dang KK, Fellay J, Heinzen EL, Feng S, Descombes P, Shianna KV, Ge D, Günthard HF, Goldstein DB, Telenti A; Swiss HIV Cohort Study; Center for HIV/AIDS Vaccine Immunology. Rotger M, et al. Among authors: telenti a. PLoS Pathog. 2010 Feb 26;6(2):e1000781. doi: 10.1371/journal.ppat.1000781. PLoS Pathog. 2010. PMID: 20195503 Free PMC article.
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
Alizon S, von Wyl V, Stadler T, Kouyos RD, Yerly S, Hirschel B, Böni J, Shah C, Klimkait T, Furrer H, Rauch A, Vernazza PL, Bernasconi E, Battegay M, Bürgisser P, Telenti A, Günthard HF, Bonhoeffer S; Swiss HIV Cohort Study. Alizon S, et al. Among authors: telenti a. PLoS Pathog. 2010 Sep 30;6(9):e1001123. doi: 10.1371/journal.ppat.1001123. PLoS Pathog. 2010. PMID: 20941398 Free PMC article.
593 results